Publications by authors named "Lawrence Lamb"

Claim this Profile
T
Temozolomide and the PARP Inhibitor Niraparib Enhance Expression of Natural Killer Group 2D Ligand ULBP1 and Gamma-Delta T Cell Cytotoxicity in Glioblastoma.
Amber B Jones, Kaysaw Tuy, Cyntanna C Hawkins, Colin H Quinn, Joelle Saad, Lawrence S Lamb

Cancers (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression.
Amber B Jones, Abbey Rocco, Lawrence S Lamb, Gregory K Friedman, Anita B Hjelmeland

Cancers (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II clinical trial of one dose of post-transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched-unrelated donor transplantation.
Omer Jamy, Raquel Innis-Shelton, Susan Bal, Ravi Paluri, Donna Salzman, Lawrence Lamb

Am J Hematol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A combined treatment regimen of MGMT-modified γδ T cells and temozolomide chemotherapy is effective against primary high grade gliomas.
Lawrence S Lamb, Larisa Pereboeva, Samantha Youngblood, G Yancey Gillespie, L Burton Nabors

Sci Rep· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation.
Ayman Saad, Lawrence Lamb, Tao Wang, Michael T Hemmer, Stephen Spellman

Biol Blood Marrow Transplant· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mobilization of Hematopoietic Progenitor Cells for Autologous Transplantation Using Pegfilgrastim and Plerixafor: Efficacy and Cost Implications.
Nicole L Watts, Marisa B Marques, Daniel B Peavey, Racquel Innis-Shelton, Ayman Saad, Lawrence S Lamb

Biol Blood Marrow Transplant· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant.
Ayman Saad, Alankrita Taneja, Antonio Di Stasi, Rehan Sarmad, Rivvi Kukkamalla, Lawrence S Lamb

Bone Marrow Transplant· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical-scale manufacturing of γδ T cells for protection against infection and disease recurrence following haploidentical peripheral blood stem cell transplantation and cyclophosphamide gvhd prophylaxis.
Lawrence S Lamb, Sailesh Pillai, Samantha Langford, Joscelyn Bowersock, Antonio Di Stasi

Bone Marrow Transplant· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of HSV-IL12 Loaded Tumor Cell-Based Vaccination in a Mouse Model of High-Grade Neuroblastoma.
David F Bauer, Larisa Pereboeva, G Yancey Gillespie, Gretchen A Cloud, Osama Elzafarany, Lawrence S Lamb

J Immunol Res· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo expansion and activation of γδ T cells as immunotherapy for refractory neuroblastoma: A phase 1 study.
Joseph G Pressey, Julia Adams, Lualhati Harkins, David Kelly, Zhiying You, Lawrence S Lamb

Medicine (Baltimore)· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of Circulating γδ T Cell Activity in an Immunocompetent Mouse Model of High-Grade Glioma.
Benjamin H Beck, Hyunggoon Kim, Rebecca O'Brien, Martin R Jadus, G Yancey Gillespie, Lawrence S Lamb

PLoS One· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2/3 (CIN2/3).
Ronald D Alvarez, Warner K Huh, Sejong Bae, Lawrence S Lamb, Michael G Conner

Gynecol Oncol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling Human Severe Combined Immunodeficiency and Correction by CRISPR/Cas9-Enhanced Gene Targeting.
Chia-Wei Chang, Yi-Shin Lai, Erik Westin, Alireza Khodadadi-Jamayran, Kevin M Pawlik, Lawrence S Lamb

Cell Rep· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paradigm shifts in the management of poor-risk chronic lymphocytic leukemia.
Racquel D Innis-Shelton, Randall S Davis, Lawrence Lamb, Shin Mineishi

Leuk Lymphoma· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety of allogeneic innate lymphocyte therapy for glioma patients with prior cranial irradiation.
Larisa Pereboeva, Lualhati Harkins, Shun Wong, Lawrence S Lamb

Cancer Immunol Immunother· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broad T-cell receptor repertoire in T-lymphocytes derived from human induced pluripotent stem cells.
Chia-Wei Chang, Yi-Shin Lai, Lawrence S Lamb, Tim M Townes

PLoS One· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CMV-independent lysis of glioblastoma by ex vivo expanded/activated Vδ1+ γδ T cells.
Andrea Knight, Hilal Arnouk, William Britt, G Yancey Gillespie, Gretchen A Cloud, Lawrence S Lamb

PLoS One· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxic and regulatory properties of circulating Vδ1+ γδ T cells: a new player on the cell therapy field?
Gabrielle M Siegers, Lawrence S Lamb

Mol Ther· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA damage responses and oxidative stress in dyskeratosis congenita.
Larisa Pereboeva, Erik Westin, Toral Patel, Ian Flaniken, Lawrence Lamb

PLoS One· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unrelated donor allogeneic hematopoietic stem cell transplantation for patients with hemoglobinopathies using a reduced-intensity conditioning regimen and third-party mesenchymal stromal cells.
Sandhya Kharbanda, Angela R Smith, Stephanie K Hutchinson, David H McKenna, James B Ball, Lawrence S Lamb

Biol Blood Marrow Transplant· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineered drug resistant γδ T cells kill glioblastoma cell lines during a chemotherapy challenge: a strategy for combining chemo- and immunotherapy.
Lawrence S Lamb, Joscelyn Bowersock, Anindya Dasgupta, G Yancey Gillespie, Yun Su

PLoS One· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence pays off for γδ T-cell therapies.
Lawrence S Lamb

Cytotherapy· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis